𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Novel RUNX1-PRDM16 fusion transcripts in a patient with acute myeloid leukemia showing t(1;21)(p36;q22)

✍ Scribed by Ikuya Sakai; Tatsushiro Tamura; Hirosi Narumi; Naoyuki Uchida; Yoshihiro Yakushijin; Takaaki Hato; Shigeru Fujita; Masaki Yasukawa


Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
215 KB
Volume
44
Category
Article
ISSN
1045-2257

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

The t(1;21)(p36;q22) is a recurrent chromosome abnormality associated with therapy‐related acute myeloid leukemia (AML). Although involvement of RUNX1 has been detected by fluorescence in situ hybridization analysis, the partner gene has not been reported previously. We identified a novel RUNX1 partner gene, __MDS1/EVI1‐__like‐gene 1 (PRDM16), in an AML patient with t(1;21). Alternative splicing of the fusion gene generates five different fusion transcripts. In two of them, the PRDM16 reading frame is maintained in the fusion with RUNX1, suggesting that the RUNX1–PRDM16 gene fusion results in the production of a protein that is highly homologous to the RUNX1–MDS1/EVI1 chimeric protein. It is suggested that PRDM16 and MDS1/EVI1 share a common molecular mechanism for the leukemogenesis of RUNX1‐associated leukemia. Characterization of the RUNX1–PRDM16 fusion protein and comparison with the RUNX1–MDS1/EVI1 protein will facilitate the understanding of the mechanisms underlying RUNX1‐associated leukemia. © 2005 Wiley‐Liss, Inc.


📜 SIMILAR VOLUMES


PRDX4, a member of the peroxiredoxin fam
✍ Yanming Zhang; Neelmini Emmanuel; Ginny Kamboj; Jianjun Chen; Muhammad Shurafa; 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 210 KB 👁 1 views

## Abstract The __AML1__ gene (also known as __RUNX1__) at 21q22 codes for core binding factor (CBF) α, which forms a heterodimer with CBF β that acts as a transcriptional activating factor. CBF is a critical regulator in the generation and differentiation of definitive hematopoietic stem cells and

A novel gene, FGA7, is fused to RUNX1/AM
✍ Fady M. Mikhail; Lionel Coignet; Nadia Hatem; Zeinab I. Mourad; Hala M. Farawela 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 517 KB

## Abstract __AML1__ is among the most frequent targets of chromosomal rearrangements in human leukemias. We report here the molecular analysis of a t(4;21)(q28;q22) that has disrupted __AML1__ in a patient with de novo T‐cell acute lymphoblastic leukemia. By using 3′‐RACE analysis, we show that th

LPXN, a member of the paxillin superfami
✍ Hai-Ping Dai; Yong-Quan Xue; Jian-Wei Zhou; Ai-Ping Li; Ya-Fang Wu; Jin-Lan Pan; 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 342 KB 👁 1 views

## Abstract __RUNX1__ (previously __AML1__) is involved in multiple recurrent chromosomal rearrangements in hematological malignances. Recently, we identified a novel fusion between __RUNX1__ and __LPXN__ from an acute myeloid leukemia (AML) patient with t(11;21)(q12;q22). This translocation genera

MLL-CBP fusion transcript in a therapy-r
✍ Kenichi Sugita; Tomohiko Taki; Yasuhide Hayashi; Hagane Shimaoka; Hisami Kumazak 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB 👁 3 views

We describe a boy with Fanconi anemia (FA) who developed acute lymphoblastic leukemia (ALL) (FAB-L1) followed by acute myeloid leukemia (AML) (FAB-M5) at relapse. The patient was diagnosed with early pre-B-cell ALL without preceding aplastic anemia and was treated with ALL-oriented chemotherapy whic